← Back to headlines
Hungarian Competition Authority Investigates High Prices and Abuses in Non-Prescription Drug Market
The Hungarian Competition Authority (GVH) has concluded one investigation and has two ongoing into the non-prescription drug market, expressing concern over high prices and abuses.
5 Mar, 04:03 — 5 Mar, 04:03
ℹOnly 1 source covers this story
